Finding recurrence risk in colorectal cancer liver metastases
Part of Cancer, Digestive system clinical trials.
This study looks at whether a combination of clinical factors and genetic tests can better predict early return of cancer in people who had surgery for colorectal cancer that spread to the liver. It may help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have colorectal cancer that has spread to the liver.
- You have had complete surgery to remove both the colon tumor and all liver tumors.
- You are healthy enough for possible treatments after surgery, like chemo or immunotherapy.
- You can provide a small piece of your liver tumor tissue for genetic testing and a blood sample within one month after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for blood/tumor signals (“biomarkers”) that may help predict outcomes in people whose colorectal cancer returns and spreads after surgery. It mainly helps researchers understand who may do better or worse, which can guide future care.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This trial compares two surgical approaches for removing liver metastases from colon cancer: anatomical resection versus nonanatomical resection. It aims to see which approach works better for people whose tumors have certain genetic changes or are on the right side of the colon.
This trial checks a blood test for “ctDNA methylation” to see who may be at higher risk of colorectal cancer returning after surgery. It may help doctors better judge whether adjuvant chemotherapy is working or needed.
This study looks at your liver tumor's immune cells and MRI images to see if the cancer is likely to come back after surgery. The goal is to better predict recurrence and personalize follow-up care.
This study looks at tumor test results and medical history to estimate your risk of the cancer coming back or spreading after early-stage colorectal cancer surgery. It may help doctors predict who needs closer follow-up in the future.
Hear when a new Colorectal Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.